bioRxivImmunology
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations
C. Jungbauer, L. Weseslindtner, L. Weidner, S. Gaensdorfer, M. R. Farcet, E. Gschaider-Reichhart, T. R. Kreil
Abstract
Transfusion of SARS-CoV-2 convalescent plasma is a promising treatment for severe COVID-19 cases, with success of the intervention based on neutralizing antibody content. Measurement by serological correlates without biocontainment needs, and an understanding of donor characteristics that may allow for targeting of more potent donors would greatly facilitate effective collection.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease
T. J. Gniadek, J. M. Thiede, … T. D. Bold·bioRxiv·Aug 7, 2020
- Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals
Guillaume Beaudoin-Bussières, Annemarie Laumaea, … Andrés Finzi·bioRxiv·Jul 9, 2020
- Limited window for donation of convalescent plasma with high live-virus neutralizing antibodies for COVID-19 immunotherapy
A. Gontu, S. Srinivasan, … S. V. Kuchipudi·bioRxiv·Aug 21, 2020
- Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
E. Salazar, S. V. Kuchipudi, … J. M. Musser·bioRxiv·Jun 8, 2020
- Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors
J. Perreault, T. Tremblay, … R. Bazin·bioRxiv·Jul 16, 2020
- High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Oct 20, 2020